“Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data”, J of Skin, vol. 6, no. 2, p. s12, Mar. 2022, doi: 10.25251/skin.6.supp.12.